0
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Inulin: a multifaceted ingredient in pharmaceutical sciences

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Received 13 Jun 2024, Accepted 18 Jul 2024, Published online: 29 Jul 2024

References

  • Falco C, et al. The chemistry of inulin and its derivatives. J Agric Food Chem. 2023;71(1):234–245.
  • Zhang L, Jiang X. Structural variability and functionality of inulin. Food Chem. 2022;372:131–140.
  • Patel S, Goyal A. Applications of inulin in health and nutrition. Nutrients. 2023;15(4):1021.
  • Roberfroid M. Prebiotic effects of inulin and oligofructose. J Nutrition. 2023;153(1):7–18.
  • Whelan K, Meyers J. Historical perspectives on inulin. J Dietary Supplement. 2023;20(2):175–182.
  • Bajaj S, Salwan R. Traditional uses and modern applications of inulin. Ethnopharmacol Rev. 2022;10(3):220–229.
  • González R, et al. Sources and extraction methods of inulin. Food Sci Technol Int. 2022;28(3):189–200.
  • Ojha C, Sharma P, Jain V. Design, optimization, and evaluation of topical gel of Cardiospermum halicacabum and Ricinus communis L. leaves extract for the treatment of rheumatoid arthritis. J Biomater Sci Polym Ed. 2024;35(10):1584–1605. doi: 10.1080/09205063.2024.2340872.
  • Molis C, et al. Economic viability of inulin production from chicory. Ind Crops Prod. 2022;174:114204.
  • Gibson GR, et al. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics including inulin and oligofructose. J Nutrition . 2022;152(2):275–292.
  • Slavin J. Inulin and oligofructose: dietary fibers with proven benefits. Adv Nutr. 2023;14(1):29–39.
  • Tungland BC. Human microbiota and prebiotics: dietary inulin and oligofructose. Curr Dev Nutr. 2023;8(3):212–225.
  • Petrosino J, et al. Inulin and its role in gut health. Front Nutr. 2023;10:1056789.
  • Kaur N, Gupta AK. Inulin: a comprehensive review on its prebiotic effects and applications. Food Rev Int. 2022;38(2):289–310.
  • Veena M, et al. Emerging roles of inulin in health and disease management. J Funct Foods. 2023;95:105182.
  • Rodríguez J, et al. Impact of inulin on gut microbiota and health: a review of clinical evidence. Gut Microbes. 2023;15(1):2134567.
  • Shu LZ, Ding YD, Xue QM, et al. Direct and indirect effects of pathogenic bacteria on the integrity of intestinal barrier. Therap Adv Gastroenterol. 2023;16:17562848231176427. May doi: 10.1177/17562848231176427.
  • Piccioni A, Covino M, Candelli M, et al. How do diet patterns, single foods, prebiotics and probiotics impact gut microbiota? Microbiol Res. 2023;14(1):390–408. 14doi: 10.3390/microbiolres14010030.
  • Ashaolu TJ, Ashaolu JO, Adeyeye SA. Fermentation of prebiotics by human colonic microbiota in vitro and short‐chain fatty acids production: a critical review. J Appl Microbiol. 2021;130(3):677–687. doi: 10.1111/jam.14843.
  • Fusco W, Lorenzo MB, Cintoni M, et al. Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients. 2023;15(9):2211. May 6 doi: 10.3390/nu15092211.
  • Ballini A, Charitos IA, Cantore S, et al. About functional foods: the probiotics and prebiotics state of art. Antibiotics (Basel). 2023;12(4):635. Mar 23doi: 10.3390/antibiotics12040635.
  • Vaghef-Mehrabani E, Harouni R, Behrooz M, et al. Effects of inulin supplementation on inflammatory biomarkers and clinical symptoms of women with obesity and depression on a calorie-restricted diet: a randomised controlled clinical trial. Br J Nutr. 2023;129(11):1897–1907. Jun doi: 10.1017/S000711452200232X.
  • Campos-Perez W, Martinez-Lopez E. Effects of short chain fatty acids on metabolic and inflammatory processes in human health. Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866(5):158900. doi: 10.1016/j.bbalip.2021.158900.
  • Rubin IM, Mollerup S, Broholm C, et al. Synbiotic intervention with Lactobacilli, Bifidobacteria, and inulin in healthy volunteers increases the abundance of Bifidobacteria but does not alter microbial diversity. Appl Environ Microbiol. 2022;88(19):e01087-22. Oct 11 doi: 10.1128/aem.01087-22.
  • Akhtar M, Chen Y, Ma Z, et al. Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation. Anim Nutr. 2022;8:350–360. Mar 1 doi: 10.1016/j.aninu.2021.11.005.
  • Yoo S, Jung SC, Kwak K, et al. The role of prebiotics in modulating gut microbiota: implications for human health. Int J Mol Sci. 2024;25(9):4834. Apr 29 doi: 10.3390/ijms25094834.
  • Dahiya D, Nigam PS. Inclusion of dietary-fibers in nutrition provides prebiotic substrates to probiotics for the synthesis of beneficial metabolites SCFA to sustain gut health minimizing risk of IBS, IBD, CRC. Recent Prog Nutr. 2023;3(3):1–15. doi-10. doi: 10.21926/rpn.2303017.
  • Akhlaghi M. The role of dietary fibers in regulating appetite, an overview of mechanisms and weight consequences. Crit Rev Food Sci Nutr. 2024;64(10):3139–3150. doi: 10.1080/10408398.2022.2130160.
  • Ferrari S, Mulè S, Parini F, et al. The influence of the gut-brain axis on anxiety and depression: a review of the literature on the use of probiotics. J Tradit Complement Med. 2024;14(3):237–255. Mar 21. doi: 10.1016/j.jtcme.2024.03.011.
  • Sharma P, Dasputre N, Jain V. Nanomedicine: concepts, characteristics, and regulatory challenges. In Smart nanocarrier for effective drug delivery. Boca Raton (FL): CRC Press; 2024. p. 1–16.
  • Ziaei R, Shahshahan Z, Ghasemi‐Tehrani H, et al. Inulin‐type fructans with different degrees of polymerization improve insulin resistance, metabolic parameters, and hormonal status in overweight and obese women with polycystic ovary syndrome: a randomized double‐blind, placebo‐controlled clinical trial. Food Sci Nutr. 2024;12(3):2016–2028. Mar doi: 10.1002/fsn3.3899.
  • Malik B, Rehman RU. Chicory inulin: a versatile biopolymer with nutritional and therapeutic properties. Medicinal and aromatic plants: healthcare and industrial applications. Singapore: Springer Nature; 2021. p. 373–390.
  • Tappy L. Metabolism of sugars: a window to the regulation of glucose and lipid homeostasis by splanchnic organs. Clin Nutr. 2021;40(4):1691–1698. doi: 10.1016/j.clnu.2020.12.022.
  • Zhang W, Tang Y, Huang J, et al. Efficacy of inulin supplementation in improving insulin control, HbA1c and HOMA-IR in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. J Clin Biochem Nutr. 2020;66(3):176–183. doi: 10.3164/jcbn.19-103.
  • Zhou X, Wang S, Xu C, et al. The leap of inulin fructans from food industry to medical application. Chem Biodivers. 2023;20(6):e202201126. Jun doi: 10.1002/cbdv.202201126.
  • Bodnaruc AM, Prud’homme D, Blanchet R, et al. Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review. Nutr Metab (Lond). 2016;13(1):92. Dec doi: 10.1186/s12986-016-0153-3.
  • Colantonio AG, Werner SL, Brown M. The effects of prebiotics and substances with prebiotic properties on metabolic and inflammatory biomarkers in individuals with type 2 diabetes mellitus: a systematic review. J Acad Nutr Diet. 2020;120(4):587–607.e2. doi: 10.1016/j.jand.2018.12.013.
  • Rekha K, Venkidasamy B, Samynathan R, et al. Short-chain fatty acid: an updated review on signaling, metabolism, and therapeutic effects. Crit Rev Food Sci Nutr. 2024;64(9):2461–2489. doi: 10.1080/10408398.2022.2124231.
  • Cicero AF, Fogacci F, Bove M, et al. Impact of a short-term synbiotic supplementation on metabolic syndrome and systemic inflammation in elderly patients: a randomized placebo-controlled clinical trial. Eur J Nutr. 2021;60(2):655–663. Mar doi: 10.1007/s00394-020-02271-8.
  • Hu Y, He J, Zheng P, et al. Prebiotic inulin as a treatment of obesity related nonalcoholic fatty liver disease through gut microbiota: a critical review. Crit Rev Food Sci Nutr. 2023;63(7):862–872. doi: 10.1080/10408398.2021.1955654.
  • Carpi RZ, Barbalho SM, Sloan KP, et al. The effects of probiotics, prebiotics and synbiotics in non-alcoholic fat liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a systematic review. Int J Mol Sci. 2022;23(15):8805. Aug 8 doi: 10.3390/ijms23158805.
  • Sharma P, Tailang M. Primaquine-loaded transdermal patch for treating malaria: design, development, and characterization. Futur J Pharm Sci. 2022;8(1):43. doi: 10.1186/s43094-022-00433-5.
  • Parada Venegas D, De la Fuente MK, Landskron G, et al. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. Front Immunol. 2019;10:1486. Mar 11 doi: 10.3389/fimmu.2019.01486.
  • Bach Knudsen KE, Lærke HN, Hedemann MS, et al. Impact of diet-modulated butyrate production on intestinal barrier function and inflammation. Nutrients. 2018;10(10):1499. doi: 10.3390/nu10101499.
  • Sheng W, Ji G, Zhang L. Immunomodulatory effects of inulin and its intestinal metabolites. Front Immunol. 2023;14:1224092. doi: 10.3389/fimmu.2023.1224092.
  • Keerthi TR, Narayanan R, Sreelekshmi K, et al. Immunity and gut microbiome: role of probiotics and prebiotics. Probiotic bacteria and postbiotic metabolites: role in animal and human health. Singapore: Springer Nature; 2021. p. 61–83.
  • Then CK, Paillas S, Moomin A, et al. Dietary fibre supplementation enhances radiotherapy tumour control and alleviates intestinal radiation toxicity. Microbiome. 2024;12(1):89. Dec doi: 10.1186/s40168-024-01804-1.
  • Zhao Y, Yu YB. Intestinal microbiota and chronic constipation. Springerplus. 2016;5(1):1130. doi: 10.1186/s40064-016-2821-1.
  • Brenner DM, Corsetti M, Drossman D, et al. Perceptions, definitions, and therapeutic interventions for occasional constipation: a Rome working group consensus document. Clin Gastroenterol Hepatol. 2024;22(2):397–412. Feb 1 doi: 10.1016/j.cgh.2023.08.044.
  • Wegh CA, Schoterman MH, Vaughan EE, et al. Effect of prebiotic oligosaccharides on bowel habit and the gut microbiota in children with functional constipation (Inside study): study protocol for a randomised, placebo-controlled, multi-centre trial. Trials. 2024;25(1):238. Apr 5 doi: 10.1186/s13063-024-08050-8.
  • Cani PD, Lecourt E, Dewulf EM, et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr. 2006;90(5):1236–1243. doi: 10.3945/ajcn.2009.28095.
  • Rault-Nania MH, et al. Inulin supplementation prevents high fat diet-induced alteration of lipid profile and metabolism in Zucker rats. J Nutr. 2006;136(8):2061–2066.
  • Silk DBA, Davis A, Vulevic J, et al. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009;29(5):508–518. doi: 10.1111/j.1365-2036.2008.03911.x.
  • He X, et al. Dietary intake of inulin and risk of colorectal cancer: a meta-analysis of observational studies. Nutrition Cancer. 2014;66(7):1044–1053.
  • Sharma P. Applications of statistical tools for optimization and development of smart drug delivery system. In Smart Drug Delivery. London: Intech Open; 2022; 183.
  • Mahdavi M, Laforest-Lapointe I, Massé E. Preventing colorectal cancer through prebiotics. Microorganisms. 2021;9(6):1325. doi: 10.3390/microorganisms9061325.
  • Rodriguez-Colman MJ, Dansen TB, Burgering BM. FOXO transcription factors as mediators of stress adaptation. Nat Rev Mol Cell Biol. 2024;25(1):46–64. doi: 10.1038/s41580-023-00649-0.
  • Shrifteylik A, Maiolini M, Dufault M, et al. A current review on the role of prebiotics in colorectal cancer. Biologics. 2023;3(3):209–231. Aug 22doi: 10.3390/biologics3030012.
  • Pankaj S, Dheerendra AD, Yogendra R, et al. S. Formulate and evaluate orodispersible tablets of Primaquine. Indo Am J Pharm Res. 2015;5(5):1625–1632.
  • Wu Y, Wu H, Hu L. Recent advances of proteins, polysaccharides and lipids-based edible films/coatings for food packaging applications: a review. Food Biophys. 2024;19(1):29–45. doi: 10.1007/s11483-023-09794-7.
  • Bernal-Chávez SA, Romero-Montero A, Hernández-Parra H, et al. Enhancing chemical and physical stability of pharmaceuticals using freeze-thaw method: challenges and opportunities for process optimization through quality by design approach. J Biol Eng. 2023;17(1):35. May 23 doi: 10.1186/s13036-023-00353-9.
  • Kvakova M, Bertkova I, Stofilova J, et al. Co-encapsulated synbiotics and immobilized probiotics in human health and gut Microbiota modulation. Foods. 2021;10(6):1297. doi: 10.3390/foods10061297.
  • Tyndall SM, Maloney GR, Cole MB, et al. Critical food and nutrition science challenges for plant-based meat alternative products. Crit Rev Food Sci Nutr. 2024;64(3):638–653. doi: 10.1080/10408398.2022.2107994.
  • Patel AR. Functional and engineered colloids from edible materials for emerging applications in designing the food of the future. Adv Funct Materials. 2020;30(18):1806809. doi: 10.1002/adfm.202070113.
  • Ding Y, Zhao T, Fang J, et al. Recent developments in the use of nanocrystals to improve bioavailability of APIs. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024;16(2):e1958. doi: 10.1002/wnan.1958.
  • Ghali ENHK, Chauhan SC, Yallapu MM. Inulin-based formulations as an emerging therapeutic strategy for cancer: a comprehensive review. Int J Biol Macromol. 2024;259(Pt 1):129216. doi: 10.1016/j.ijbiomac.2024.129216.
  • Han J, McClements DJ, Liu X, et al. Oral delivery of probiotics using single‐cell encapsulation. Compr Rev Food Sci Food Saf. 2024;23(3):e13322. May doi: 10.1111/1541-4337.13322.
  • Kashani GK, Naghib SM, Soleymani S, et al. A review of DNA nanoparticles-encapsulated drug/gene/protein for advanced controlled drug release: current status and future ­perspective over emerging therapy approaches. Int J Biol Macromol. 2024;268(Pt 1):131694. Apr 18:doi: 10.1016/j.ijbiomac.2024.131694.
  • Liu F, et al. Recent advances in inulin-based drug delivery systems. Drug Deliver Translat Res. 2023;12(3):589–603.
  • Chen Y, et al. Inulin-based nanoparticles for targeted drug delivery: a review. J Nanomed Res. 2022;14(2):210–219.
  • Smith AM, Stojanovic A. Inulin and its applications in drug delivery systems. J Drug Delivery Sci Technol. 2023;70:103002.
  • Tang S, et al. Inulin nanoparticles for drug delivery: a review of recent advances. Int J Pharm. 2023;620:120702.
  • Zhang H, et al. Biodegradable inulin-based nanoparticles for controlled drug release. J Controlled Release. 2022;345:234–245.
  • Gupta P, Kaur A. Targeted delivery of anticancer drugs using inulin nanoparticles. Eur J Pharm Sci. 2023;172:106099.
  • Zhang Y, et al. Inulin-based nanoparticles for efficient drug delivery. J Controlled Release. 2018;287:40–54.
  • Sharma P, Bhargava S, Parashar D, et al. Formulation and evaluation of nanoparticles containing cyclophosphamide. WJPR. 2017;7(1):785–798.
  • Gonzalez-Mira E, et al. Inulin microparticles for targeted vaginal delivery. Pharm Res. 2011;28(7):1709–1719.
  • Ogunwale JA, et al. Development and characterization of inulin-based liposomes for enhanced drug delivery. Drug Deliver Lett. 2020;10(2):154–163.
  • Sharma P, Tailang M. Opportunities and challenges to develop transdermal patch with nanocarrier. WJPR. 2017;6(15):392–400.
  • Chung YI, et al. Inulin-based polymeric micelles for protection and delivery of lipophilic drugs. J Pharm Sci. 2009;98(12):4803–4816.
  • Li C, et al. Inulin-based hydrogels for enhanced loading and sustained release of hydrophobic drugs. Carbohydr Polym. 2016;147:272–279.
  • Sharma P. Design, optimization, and characterization of herbal gel for facial application. Asian J Pharmaceut (AJP). 2023;17(03):486–498.
  • Liu C, et al. Biocompatible inulin hydrogels for biomedical applications. Carbohydr Polym. 2023;305:120536.
  • Wang J, et al. Controlled drug release from inulin hydrogels: a review. J Biomed Mater Res Part A. 2022;110(12):2345–2356.
  • Singh V, Sharma P. Inulin-based hydrogels for wound healing applications. Int J Biol Macromol. 2023;221:456–465.
  • Sharma P, Jain V. An overview of current advances and pharmaceutical uses of 3D and 4D printing. Explor Med. 2023;4:560–575. doi: 10.37349/emed.2023.00161.
  • Zhang H, Chen L. Stimuli-responsive inulin hydrogels for targeted drug delivery. Adv Healthcare Mater. 2023;12(5):230456.
  • Chen Y, et al. Inulin-based microspheres for localized drug delivery: a promising approach for infection treatment. Drug Develop Indus Pharma. 2022;48(9):1431–1440.
  • Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125(6):1401–1412. doi: 10.1093/jn/125.6.1401.
  • Delzenne NM, Cani PD. Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr. 2011;31(1):15–31. doi: 10.1146/annurev-nutr-072610-145146.
  • Kelly JR, Kennedy PJ, Cryan JF, et al. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci. 2015;9:392. doi: 10.3389/fncel.2015.00392.
  • Langlands SJ, et al. Prebiotic carbohydrates modify the mucosa associated microbiota in the human colon. Gut Microbes. 2018;9(6):562–573.
  • Sharma P, Tailang M. PH dependent release potential of natural polymers in sustained release of ornidazole from colon targeted delivery system. IJJT. 2019;9:10.
  • Vandeputte D, et al. Prebiotic inulin type fructans intervention in uc patients modulates colonic microbiota composition and mucosal biochemistry: results from a randomized placebo-controlled cross-over study. Gut. 2017;66(9):1631–1638.
  • Sharma P, Jain V, Jain A, et al. Role of swarm intelligence for health monitoring and related actions. In Internet of Things and fog computing-enabled solutions for real-life challenges. Boca Raton (FL): CRC Press; 2022; p. 95–118.
  • Akram W, et al. Fructooligosaccharides: a review on extraction, purification, animal studies, and human trials. J Cereal Sci. 2020;93:102995.
  • Delgado GT, et al. Prebiotics modulate the effects of fructose-induced hepatic steatosis and alter the gut microbiota composition in rats. J Nutrition . 2017;147(2):209–218.
  • So D, Whelan K, Rossi M, et al. Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. Am J Clin Nutr. 2019;107(6):965–983. doi: 10.1093/ajcn/nqy041.
  • Canfora EE, Meex RCR, Venema K, et al. Gut microbial metabolites in obesity, NAFLD and T2DM. Nat Rev Endocrinol. 2015;15(5):261–273. doi: 10.1038/s41574-019-0156-z.
  • Bindels LB, et al. Towards a prebiotic-based treatment for depression? Gut Microbes. 2015;6(1):24–26.
  • Brighenti F, et al. Dietary inulin and oligofructose: effects on metabolic risk factors in patients with type 2 diabetes. J Nutrition . 2018;148(7):1253–1261.
  • Slavin JL. Fiber and prebiotics: mechanisms and health benefits. Nutrients. 2013;5(4):1417–1435. doi: 10.3390/nu5041417.
  • Lecerf JM, Dépeint F. Fibre intake and cardiovascular risk. J Cardiovasc Develop Disease. 2018;5(2):23.
  • Causey JL, Feirtag JM, Gallaher DD, et al. Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal environment in hypercholesterolemic men. Nutr Res. 2000;20(2):191–201. doi: 10.1016/S0271-5317(99)00152-9.
  • Scott KP, Martin JC, Duncan SH, et al. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiol Ecol. 2014;87(1):30–40. doi: 10.1111/1574-6941.12186.
  • Micka A, et al. Effect of inulin supplementation on faecal microbiota and butyrate in patients with inflammatory bowel disease. Clinical Nutrition. 2017;36(5):1133–1141.
  • Kolida S, et al. A double-blind, placebo-controlled, cross-over study to establish the bifidogenic dose of inulin in healthy humans. Eur J Clin Nutr. 2020;64(7):762–772.
  • Sharma P, Jain V, Tailang M. Advancement of nanocarrier-based engineering for specific drug delivery for cancer therapy. In Targeted cancer therapy in biomedical engineering. Singapore: Springer Nature Singapore; 2023; p. 465–486.
  • U.S. Food and Drug Administration (FDA). GRAS Notice for Inulin; 2018. FDA GRAS Notices. https://www.fda.gov/news-events/press-announcements/biden-harris-administration-announces-national-strategy-reduce-food-loss-and-waste-and-recycle. [Last access on 05 April 2024].
  • Grabitske HA, Slavin JL. Gastrointestinal effects of low-digestible carbohydrates. Crit Rev Food Sci Nutr. 2009;49(4):327–360. doi: 10.1080/10408390802067126.
  • European Food Safety Authority (EFSA). Scientific opinion on the safety of inulin and oligofructose. EFSA J. 2015;13(1):3950.
  • Ashwell M. Regulatory status of inulin and oligofructose: a comprehensive review. Nutr Res Rev. 2015;28(1):120–130.
  • European Food Safety Authority (EFSA). Scientific opinion on the substantiation of health claims related to inulin-type fructans and maintenance of normal blood LDL-cholesterol concentrations. EFSA J. 2010;8(10):1796.
  • Food Standards Australia New Zealand (FSANZ). 2013. Inulin: a non-digestible carbohydrate with prebiotic properties. FSANZ Reports. Retrieved from FSANZ website.
  • U.S. Food and Drug Administration (FDA). Generally Recognized as Safe (GRAS) Notification for Inulin; 2020. https://www.fda.gov/food/gras-notice-inventory/recently-published-gras-notices-and-fda-letters [Last access on 05 April 2024].
  • FDA Inactive Ingredient Database. Inulin; 2020. https://www.fda.gov/drugs/drug-approvals-and-databases/inactive-ingredients-database-download [Last access on 05 April 2024].
  • European Food Safety Authority (EFSA). Scientific Opinion on the Re-Evaluation of Inulin (E 440) as a Food Additive. EFSA J. 2017;15(3):e04780.
  • European Pharmacopoeia. Monograph on Inulin; 2020. https://www.edqm.eu/en/european-pharmacopoeia-ph.-eur.-11th-edition [Last access on 01 May 2024].
  • Health Canada. List of Permitted Sweeteners; 2019. https://www.canada.ca/en/health-canada/services/food-nutrition/food-safety/food-additives/lists-permitted/9-sweeteners.html. [Last access on 28 April 2024]
  • Health Canada Drug Product Database. Inulin; 2020. https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html. [Last access on 30 April 2024]
  • Ministry of Health, Labour, and Welfare (Japan). 2015.
  • Japanese Pharmacopoeia. 2016 (17th ed.). Monograph on Inulin.
  • Hustoft TN, et al. Effects of inulin on symptoms, gut microbiota and fermentation in patients with IBS: a randomized, placebo-controlled crossover trial. Amer J Clin Nutri. 2017;105(6):1256–1265.
  • Al-Tamimi EK, et al. Symptomatic response to different fermentable carbohydrate inulin in subjects with inflammatory bowel disease. Clinical Nutrition. 2010;29(3):329–334.
  • Korakli M, et al. Enzymatic modification of inulin enhances its prebiotic and functional properties. J Biotechnol. 2018;283:67–74.
  • Graça C, et al. Encapsulation of inulin in food products: a strategy to improve its stability and health benefits. Food Hydrocolloids. 2020;108:106046.
  • Pérez-López AJ, et al. Impact of processing on the stability of inulin and its functional properties. Food Res Int. 2018;105:650–658.
  • Vajdi M, Khorvash F, Rouhani MH, et al. Effect of inulin supplementation on clinical symptoms, inflammatory and oxidative stress markers in women with migraine: study protocol for a randomized clinical trial. Trials. 2023;24(1):722. Nov 11 doi: 10.1186/s13063-023-07765-4.
  • Delzenne NM, et al. Prebiotics and their effects on metabolic diseases. Diabetes Care. 2019;42(10):1777–1784.
  • Vulevic J, et al. Influence of prebiotic inulin-type fructans on immune function and inflammation. J Nutri Biochem. 2018;57:94–101.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.